NCT04482426

Brief Summary

The study aimed to explore and quantify functional and electrical activities in different pelvic floor muscle groups, to differentiate the electrophysiological role in different pelvic floor muscle groups relating to pelvic floor dysfunction or disorders, and further to develop treatment strategies for different pelvic floor muscle groups in different female pelvic disorders.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2014

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 25, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2015

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2017

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

July 19, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 22, 2020

Completed
Last Updated

July 22, 2020

Status Verified

July 1, 2020

Enrollment Period

1.1 years

First QC Date

July 19, 2020

Last Update Submit

July 21, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Contraction of pelvic floor muscle

    Chart review

    Baseline

Eligibility Criteria

Age20 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women with pelvic floor dysfunction

You may qualify if:

  • Women with pelvic floor dysfuntion

You may not qualify if:

  • Pregnant women
  • Women with histories of diabetes, cerebrovascular diseases, neurological diseases, degenerative muscular diseases, or autoimmune connective tissue diseases。

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 19, 2020

First Posted

July 22, 2020

Study Start

July 25, 2014

Primary Completion

August 29, 2015

Study Completion

August 11, 2017

Last Updated

July 22, 2020

Record last verified: 2020-07